Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1995-04-20
1997-03-04
Rollins, John W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
514885, 514894, 514934, A61K 3578
Patent
active
056076738
ABSTRACT:
In HIV infected individuals, certain clinical and biological markers are used to assess the progression or regression of the disease. From the plant, Uvaria bevistipitata of the Annonaceae family, a substantially pure extract was derived. This extract was administered to 268 HIV infected patients in a clinical trail in Zaire Africa and dramatic results were obtained. The extract was also submitted to a laboratory for in vitro analysis. when tested against the HIV reverse transcriptase enzyme, the extract tested 96.7% active. In further laboratory analysis, against HIV-.sub.IIB, it demonstrated efficacy at doses that showed no cytotoxic effects.
REFERENCES:
patent: 4721727 (1988-01-01), Kolajczak et al.
patent: 4855319 (1989-08-01), Kolajczak et al.
patent: 5229419 (1993-07-01), Win et al.
Jolad, et al, J. Org. Chem. 47:3151-3153, 1982.
Cole, et al., J. Org. Chem. 41:1852-1855, 1976.
Padmaja, et al., J. Ethropharmacol. 40: 181-186, 1993.
Lumonadio, et al., J. Ethropharmacol. 31:59-65, 1991.
C.S.S.A.H.A., Inc.
Rollins John W.
LandOfFree
Purified extract of uvaria brevistipitata and a process for obta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purified extract of uvaria brevistipitata and a process for obta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified extract of uvaria brevistipitata and a process for obta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2144304